BioPharma Dive ٨ أبريل ٢٠٢٦ Novo underprices Lilly with higher-dose Wegovy; Insmed absorbs ‘expected’ study failure
FierceBiotech ٧ أبريل ٢٠٢٦ Lilly pays AC Immune $12.5M to expand Alzheimer’s collab as asset draws closer to clinic
Endpoints News ٢ أبريل ٢٠٢٦ Novo and Lilly battle over GLP-1 claims only a head-to-head trial can answer
Endpoints News ٢ أبريل ٢٠٢٦ Eli Lilly's chief technology officer retires after 35 years; Astellas strategy exec resigns
Endpoints News ١ أبريل ٢٠٢٦ Lilly wins approval of anti-obesity pill orforglipron, setting up new battle with Novo
FierceBiotech ٣١ مارس ٢٠٢٦ Lilly pays $6.3B upfront for sleep disorder-focused Centessa in latest neuroscience play
Insilico Medicine ٢٩ مارس ٢٠٢٦ Insilico Medicine Announces Global R&D Collaboration with Lilly - Insilico Medicine
FierceBiotech ٢٣ مارس ٢٠٢٦ Apogee eczema data drive hype to new peak as threat to Lilly and Sanofi becomes clear
Endpoints News ٢٠ مارس ٢٠٢٦ UK’s NICE revisits Lilly, Eisai Alzheimer's drugs under new pricing threshold